prevalence of systemic lupus erythematosus in a sample of Egyptian myasthenia gravis patients

Myasthenia gravis and systemic lupus erythematosus, which precedes the other?

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

PACTR

Registry ID

PACTR202502885631676

Enrollment

Registered

2025-02-03

Start date

2024-05-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nervous System Diseases

Interventions

myasthenia gravis group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: confirmed myasthenia gravis patients

Exclusion criteria

Exclusion criteria: 1-age less than 16 years 2-patients not fulfilling the diagnosis for myasthenia gravis

Design outcomes

Primary

Measure	Time frame
to identify the percentage of SLE patients among myasthenia garvis	—

Secondary

Measure	Time frame
1-characteristics of patients discovered to be SLE with Myasthenia Gravis	—

Countries

Egypt

Contacts

Public ContactAya Zhran

lecturer of neurology faculty of medicine Mansoura university

Aya_zhran@mans.edu.eg00201090360072

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026